spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ULURU 

 HSMN NewsFeed - 5 Sep 2013
ULURU Inc. Extends The International Altrazeal(R) License To Include Additional Territories
Devices Wound Care Licensing
 HSMN NewsFeed - 26 Aug 2013
ULURU Inc. Announces A Publication In The International Wound Journal On A Clinical Study Using Altrazeal(R)
Devices Wound Care
 HSMN NewsFeed - 28 May 2013
ULURU Inc. Announces Publication On Altrazeal(R) In The International Journal Of Molecular Sciences
Devices Wound Care
 HSMN NewsFeed - 3 May 2012
ULURU Inc. Provides Update of Clinical Activities for Altrazeal
Devices Wound Care
 HSMN NewsFeed - 23 Feb 2012
ULURU Inc. Announces Approval to Market Altrazeal(R) in Australia
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 17 Jan 2012
ULURU Inc. Completes Altrazeal(R) License Agreement for Europe
Devices Wound Care Licensing
 HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 7 Jun 2010
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
Biopharmaceuticals Drug Delivery Wound Care Personnel
 HSMN NewsFeed - 24 Sep 2009
ULURU Inc. Presents Data on Negative Pressure Related to Altrazeal(TM) at the Diabetic Limb Salvage Conference in Washington, D.C.
Devices Wound Care
 HSMN NewsFeed - 16 Sep 2009
ULURU Inc. Presents Results of First Randomized Clinical Trial for Altrazeal(TM) at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Washington D.C.
Devices Wound Care
 HSMN NewsFeed - 5 May 2009
ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 6 Apr 2009
ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2009
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2008
ULURU Inc. Provides Details On Altrazeal(TM) Launch
Devices Wound Care
 HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
European Zindaclin Licensing Agreements Restructured; Zindaclin Rights for U.S. Market Licensed; Revenue From Zindaclin Projected at $2.5 Million in 2007
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
ULURU
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.